TICAGRELOR PROPHARM 90 MG
Land: Israel
Sprog: engelsk
Kilde: Ministry of Health
Nogle dokumenter til dette produkt er ikke tilgængelige i øjeblikket, du kan sende en anmodning til vores kundeservice, og vi vil underrette dig, så snart vi er i stand til at få dem.
Send anmodning.
Send anmodning.
Aktiv bestanddel:
TICAGRELOR
Tilgængelig fra:
PROPHARM LTD
ATC-kode:
B01AC24
Lægemiddelform:
FILM COATED TABLETS
Sammensætning:
TICAGRELOR 90 MG
Indgivelsesvej:
PER OS
Recept type:
Required
Fremstillet af:
ADALVO LIMITED, MALTA
Terapeutisk område:
TICAGRELOR
Terapeutiske indikationer:
TICAGRELOR PROPHARM is indicated for co-administered with acetylsalicylic acid (ASA), is indicated for the prevention of atherothrombotic events in adult patients with - acute coronary syndromes (ACS) or- a history of myocardial infarction (MI) and a high risk of developing an atherothrombotic event Limitations of use: 90 mg twice daily during the first year after an ACS event followed by 60 mg twice daily for additional 2 years.
Autorisation dato:
2023-08-06
